Table 1.
Baseline characteristics of study participants.
| Characteristic | n = 206 cases |
|---|---|
| Demographics | |
| Age (±SD) | 51.3 ± 13.6 |
| Male (%) | 123 (59.7%) |
| Type of hematologic malignancy | |
| Acute leukemia | 71 (34.5%) |
| Chronic leukemia | 14 (6.8%) |
| Lymphoma | 69 (33.5%) |
| Myeloma | 21 (10.2%) |
| Other | 31 (15%) |
| Admission diagnosis | |
| Hemodynamic | 79 (38.3%) |
| Metabolic | 5 (2.4%) |
| Neurologic | 16 (7.8%) |
| Postarrest care | 7 (3.4%) |
| Postoperative | 17 (8.3%) |
| Respiratory | 82 (39.8%) |
| Other | 2 (1.0%) |
| Median ICU length of stay (IQR) | 3.0 (6.0) |
| Stem cell transplant | 92 (44.7%) |
| Patients requiring readmission | 27 (13.1%) |
| Admission characteristics | |
| GVHD | 33 (13.1%) |
| Anemia on admission | 205 (99.5%) |
| Neutropenia on admission | 103 (50%) |
| Febrile neutropenia | 117 (56.8%) |
| Thrombocytopenia on admission | 178 (86.4%) |
| Infection on admission | 148 (71.8%) |
| Steroid use prior to ICU | 156 (75.7%) |
| Venoocclusive disease | 18 (8.7%) |
Data presented as number of patients and % in brackets unless otherwise specified.
ICU: intensive care unit; GVHD: graft versus host disease.